A version of this story appeared in D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
WASHINGTON — Former FDA Commissioner Scott Gottlieb is skeptical of the hype around CBD dietary supplements, at least until some hard science is published.
About the Author Reprints
